文献速递神经儿科影像MR

症状前脑型肾上腺脑白质营养不良早期病灶生长的纵向分析

A Longitudinal Analysis of Early Lesion Growth in Presymptomatic Patients with Cerebral Adrenoleukodystrophy.
PubMed 文献 · AJNR Am J Neuroradiol · 2021-09-09

该回顾性研究对36例症状前男性脑型肾上腺脑白质营养不良患者的174次MRI进行病灶体积定量,发现早期病灶可在影像学稳定时持续生长,进展型病灶呈持续加速增长,且生长轨迹在症状出现前即可区分进展型与静止型。定量MRI病灶体积测量有助于在症状前预测表型并筛选治疗候选者。

要点

  • 早期病灶在影像学稳定时仍可能持续生长,需定量体积测量而非仅凭视觉判断。
  • 进展型脑型肾上腺脑白质营养不良病灶呈持续加速度增长,可据此在症状前区分表型。
  • 早期脑病进展与年龄负相关,年轻患者进展更快。

核心结论

  • 定量测量新发脑病灶的纵向体积变化可在症状出现前区分脑型肾上腺脑白质营养不良的表型。
  • 结合患者整体临床表现,定量MRI病灶体积测量有助于准确预测适合治疗的患者。

研究设计与样本

  • 回顾性研究,纳入36例症状前男性脑型肾上腺脑白质营养不良患者,共174次MRI。
  • 病灶由人工分割,采用受试者特定的病灶强度阈值法。
  • 计算病灶体积并绘制时间曲线,计算连续两次MRI间的病灶速度和三次MRI间的加速度。
  • 采用线性混合效应模型评估进展型与静止型表型间生长参数的差异。

关键影像表现/征象

  • 早期病灶可在影像学表现稳定时仍持续生长。
  • 进展型脑型肾上腺脑白质营养不良病灶呈持续加速度增长。
  • 进展型与静止型表型的生长轨迹在症状前时期即出现分离。

诊断标准与关键数值

  • 进展型脑型肾上腺脑白质营养不良病灶加速度β=0.10 mL/month²(95% CI,0.05-0.14 mL/month²),P<.001。
  • 早期脑病进展与年龄呈负相关(ρ=-0.6631,P<.001)。
  • 患者中位年龄7.4岁(范围3.9-37.0岁)。

临床应用与阅片要点

  • 对症状前脑型肾上腺脑白质营养不良患者,应进行定量病灶体积纵向测量,而非仅依赖视觉评估。
  • 注意早期病灶在影像学稳定时仍可能生长,避免遗漏进展。
  • 结合年龄因素,年轻患者早期脑病进展可能更快。

局限性

  • 回顾性研究设计。
  • 病灶分割采用人工方法,可能存在操作者依赖性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Cerebral adrenoleukodystrophy is a devastating neurological disorder caused by mutations in the ABCD1 gene. Our aim was to model and compare the growth of early cerebral lesions from longitudinal MRIs obtained in presymptomatic patients with progressive and arrested cerebral adrenoleukodystrophy using quantitative MR imaging-based lesion volumetry.

MATERIALS AND METHODS: We retrospectively quantified and modeled the longitudinal growth of early cerebral lesions from 174 MRIs obtained from 36 presymptomatic male patients with cerebral adrenoleukodystrophy. Lesions were manually segmented using subject-specific lesion-intensity thresholding. Volumes were calculated and plotted across time. Lesion velocity and acceleration were calculated between sequentially paired and triplet MRIs, respectively. Linear mixed-effects models were used to assess differences in growth parameters between progressive and arrested phenotypes.

RESULTS: The median patient age was 7.4 years (range, 3.9-37.0 years). Early-stage cerebral disease progression was inversely correlated with age (ρ = -0.6631, P < .001), early lesions can grow while appearing radiographically stable, lesions undergo sustained acceleration in progressive cerebral adrenoleukodystrophy (β = 0.10 mL/month2 [95% CI, 0.05-0.14 mL/month2], P < .001), and growth trajectories diverge between phenotypes in the presymptomatic time period.

CONCLUSIONS: Measuring the volumetric changes in newly developing cerebral lesions across time can distinguish cerebral adrenoleukodystrophy phenotypes before symptom onset. When factored into the overall clinical presentation of a patient with a new brain lesion, quantitative MR imaging-based lesion volumetry may aid in the accurate prediction of patients eligible for therapy.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Mallack EJ, Askin G, van de Stadt S, et al. A Longitudinal Analysis of Early Lesion Growth in Presymptomatic Patients with Cerebral Adrenoleukodystrophy. AJNR Am J Neuroradiol. 2021. PMID: 34503945. doi:10.3174/ajnr.A7250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。